SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-030716
Filing Date
2013-05-21
Accepted
2013-05-21 12:07:41
Documents
3
Period of Report
2013-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v345811_8k.htm 8-K 13885
2 EXHIBIT 99.1 v345811_ex99-1.htm EX-99.1 7700
3 GRAPHIC image_001.jpg GRAPHIC 3104
  Complete submission text file 0001144204-13-030716.txt   27300
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 13860752
SIC: 2834 Pharmaceutical Preparations